Low‐ and very low‐dose buprenorphine induction: new(ish) uses for an old(ish) medication?

Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial

(2021) James S. H. Wong et al.   Addiction Science & Clinical Practice

Choosing appropriate language to reduce the stigma around mental illness and substance use disorders

(2021) Nora D. Volkow et al.   NEUROPSYCHOPHARMACOLOGY

Recommended Use of Terminology in Addiction Medicine

(2020) Richard Saitz et al.   Journal of Addiction Medicine

Hospital-based Buprenorphine Micro-dose Initiation

(2020) Melissa B. Weimer et al.   Journal of Addiction Medicine

Phase 0/microdosing approaches: time for mainstream application in drug development?

(2020) Tal Burt et al.   NATURE REVIEWS DRUG DISCOVERY

Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review

(2020) Genís Ona et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Predictive Value of Microdose Pharmacokinetics

(2019) Merel van Nuland et al.   CLINICAL PHARMACOKINETICS

Transferring Patients From Methadone to Buprenorphine

(2018) Nicholas Lintzeris et al.   Journal of Addiction Medicine

Changing the Language of Addiction

(2016) Michael P. Botticelli et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Einleitung einer Substitutionsbehandlung mit Buprenorphin unter vorübergehender Überlappung mit Heroinkonsum: ein neuer Ansatz („Berner Methode”)

(2010) R. Hämmig   Suchttherapie